|
Welcome to The Scientist's special supplement. Scroll down for the table of contents. Please download the flash player to view this content
|
The region is a powerhouse of human capital in a network of research institutions, academia, pharmaceuticals, biotechs, and industry support services.
The large pharma corporations provide an anchor to the life sciences.
The presence of Big Pharma creates a cottage industry of service-oriented companies, from CMOs to law offices to CROs.
A champion for the region.
The gulf between idea and actual product gets smaller due, in large part, to the assistance provided by many state-funded organizations or private firms.
The making of a venture capitalist.
Hopes are high that the 2006 upsurge of venture capital support signals a new trend.
Jobs are plentiful in the Philadelphia region.
Educators help to keep graduates in the region.
Tech transfer offices devise new methods to successfully connect with industry.
Industry experts tell how to create or sell a life science company.
Early-stage funding is the oxygen of young life science companies struggling to stay alive.
Open doors lead a scientist to his calling.
A focus on smaller business opportunities passed up by Big Pharma spells success.
Cephalon celebrates its 20th year.
Big Pharma teams up with smaller partners to move science forward.
Scientists at Fraunhofer USA in Delaware look to create vaccine antigens from an unlikely source.
DuPont researchers work to make biofuels a viable energy alternative.
Still searching for answers after all these years.
A conversation with Penn’s renowned ethicist.
A review of ongoing research in the tri-state area.
Greater Philadelphia offers something to fit every budget and lifestyle.
Industry professionals connect with colleagues and future partners in a variety of ways.
 |
